Affymetrix (AFFX -0.8%) says it's subsidiary, eBioscience, has sold its TrueBlot IP/Western blot...


Affymetrix (AFFX -0.8%) says it's subsidiary, eBioscience, has sold its TrueBlot IP/Western blot product line to Rockland Immunochemicals, a biotechnology company focusing on antibodies and antibody based tools for R&D and preclinical studies. TrueBlot reagents are used in Western blotting, a technique used in both scientific research and medical diagnosis to determine expression and quantitate target proteins in biological samples.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs